Molecular Templates Announces Presentations at the American Society of Hematology (ASH) 2019 Annual Meeting
09 déc. 2019 10h00 HE
|
Molecular Templates, Inc.
AUSTIN, Texas, Dec. 09, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM) a clinical-stage biopharmaceutical company focused on the discovery and development of the Company’s...
Molecular Templates to Present at Two December Investor Conferences
26 nov. 2019 08h00 HE
|
Molecular Templates, Inc.
AUSTIN, Texas, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of the Company’s...
Molecular Templates, Inc. Announces Pricing of $50.0 Million Public Equity Offering
21 nov. 2019 07h00 HE
|
Molecular Templates, Inc.
AUSTIN, Texas, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM) (the “Company” or “Molecular”), a clinical-stage biopharmaceutical company focused on the discovery and...
Molecular Templates, Inc. Announces Proposed Public Equity Offering
20 nov. 2019 16h01 HE
|
Molecular Templates, Inc.
AUSTIN, Texas, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM) (the “Company” or “Molecular”), a clinical-stage biopharmaceutical company focused on the discovery and...
Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants
18 nov. 2019 07h00 HE
|
Molecular Templates, Inc.
-Molecular Templates to receive $38 million upfront payment, including equity investment, with potential for additional milestone and royalty payments on future sales- BOSTON and AUSTIN, Texas, Nov. ...
Molecular Templates, Inc. Reports Third Quarter 2019 Financial Results
12 nov. 2019 17h00 HE
|
Molecular Templates, Inc.
AUSTIN, Texas, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular,” “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the...
Molecular Templates Hosting Analyst & Investor Meeting
07 nov. 2019 16h27 HE
|
Molecular Templates, Inc.
AUSTIN, Texas, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s...
Molecular Templates to Present at the Ladenburg Thalmann and Cantor Fitzgerald Healthcare Conferences
23 sept. 2019 16h30 HE
|
Molecular Templates, Inc.
AUSTIN, Texas, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s...
Molecular Templates, Inc. Reports Second Quarter 2019 Financial Results
12 août 2019 16h30 HE
|
Molecular Templates, Inc.
AUSTIN, Texas, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular,” “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the...
Molecular Templates Announces FDA Acceptance of IND Application for TAK-169, An Engineered Toxin Body Targeting CD38
17 juin 2019 08h00 HE
|
Molecular Templates, Inc.
TAK-169 Represents a Novel Mechanism of Action Targeting CD38Phase I Study to be Conducted in Relapsed/Refractory Multiple Myeloma Patients AUSTIN, Texas, June 17, 2019 (GLOBE NEWSWIRE) --...